Intellia Therapeutics Inc buy Royal Bank of Canada
Start price
08.08.25
/
50%
€9.24
Target price
08.08.26
€18.01
Performance (%)
37.51%
Price
17.04.26
€12.70
Summary
This prediction is currently active. With a performance of 37.51% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 08.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 10.243% | 10.243% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank Of Canada from $25.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€20.95
19.09.24
19.09.24
€48.55
19.09.25
19.09.25
-35.54%
20.09.25
20.09.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€19.65
09.08.24
09.08.24
€49.44
09.08.25
09.08.25
-52.65%
10.08.25
10.08.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€65.49
10.11.24
10.11.24
-30.16%
11.11.24
11.11.24